Recap: Atea Pharmaceuticals Q4 Earnings
Recap: Atea Pharmaceuticals Q4 Earnings
Atea Pharmaceuticals (NASDAQ:AVIR) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Atea Pharmicals(納斯達克股票代碼:AVIR)於2024年2月28日星期三下午4點05分公佈了其第四季度業績。
Here's what investors need to know about the announcement.
以下是投資者需要了解的有關該公告的信息。
Earnings
收益
Atea Pharmaceuticals beat estimated earnings by 6.0%, reporting an EPS of $-0.47 versus an estimate of $-0.5.
Atea Pharmicals的收益比預期高出6.0%,每股收益爲-0.47美元,而預期爲-0.5美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
過去的收益表現
Last quarter the company beat on EPS by $0.08 which was followed by a 9.0% drop in the share price the next day.
上個季度,該公司的每股收益高出0.08美元,隨後第二天股價下跌了9.0%。
To track all earnings releases for Atea Pharmaceuticals visit their earnings calendar here.
要追蹤Atea Pharmaceuticals的所有業績,請在此處訪問其業績日曆。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動內容引擎生成,並由編輯審閱。
譯文內容由第三人軟體翻譯。